Literature DB >> 2677960

Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect.

F Van Bel1, M Van de Bor, T Stijnen, J Baan, J H Ruys.   

Abstract

Indomethacin decreases cerebral blood flow velocity and blood flow in the preterm infant. The duration of this negative effect has not been established. Cerebral blood flow velocity was evaluated in 24 preterm infants with symptomatic patent ductus arteriosus before and during the first 12 hours after a single intravenous dose of indomethacin, 0.1 mg/kg. Cerebral blood flow velocity was estimated by serial Doppler investigations of the anterior cerebral arteries. Indomethacin administration led to an instantaneous decrease of peak systolic flow velocity, temporal mean flow velocity, and end-diastolic flow velocity of the anterior cerebral arteries in all infants, which was maximal between 2 and 40 minutes after indomethacin administration and was followed by a more sustained recovery of all velocities to baseline values. Temporal mean flow velocity was not different from pre-indomethacin values at 3 hours after the administration. It is concluded that indomethacin can impact the cerebral circulation of the preterm infant for at least 2 hours. This may have consequences in preterm infants with unstable hemodynamics and pulmonary function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677960

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

Review 1.  Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

Authors:  C Hammerman; M Kaplan
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2019-06-21

3.  Variability in cerebral oxygen delivery is reduced in premature neonates exposed to chorioamnionitis.

Authors:  Toby D Yanowitz; Douglas M Potter; A'delbert Bowen; Robyn W Baker; James M Roberts
Journal:  Pediatr Res       Date:  2006-02       Impact factor: 3.756

4.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2020-01-27

5.  Treatment of patent ductus arteriosus with ibuprofen.

Authors:  B Van Overmeire; I Follens; S Hartmann; W L Creten; K J Van Acker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

6.  Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.

Authors:  Karen E Corff; Kris C Sekar
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

Review 7.  Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.

Authors:  Palmer G Johnston; Maria Gillam-Krakauer; M Paige Fuller; Jeff Reese
Journal:  Clin Perinatol       Date:  2012-01-13       Impact factor: 3.430

Review 8.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

9.  Near-infrared spectroscopy for detection of a significant patent ductus arteriosus.

Authors:  Valerie Y Chock; Laura A Rose; Jeanet V Mante; Rajesh Punn
Journal:  Pediatr Res       Date:  2016-09-07       Impact factor: 3.756

10.  The effect of dexamethasone on time averaged mean velocity in the middle cerebral artery in very low birth weight infants.

Authors:  A Ohlsson; J Bottu; J Govan; M L Ryan; T Myhr; K Fong
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.